Reproducibility for Heart Rate Variability Analysis during 6-Min Walk Test in Patients with Heart Failure and Agreement between Devices

Author(s):Show less -

Braga, Lays Magalhaes ; Prado, Gustavo Faibischew ; Kikuchi Umeda, Iracema Ioco ; Kawauchi, Tatiana Satie ; Froes Taboada, Adriana Marques ; Azevedo, Raymundo Soares ; Pereira Filho, Horacio Gomes ; Grupi, Cesar Jose ; Cavenague Souza, Hayala Cristina ; Ribeiro Moreira, Dalmo Antonio ; Nakagawa, Naomi Kondo

• Document type: Journal article
• Source: PLoS One; v. 11, n. 12 DEC 9 2016.
• Web of Science Citations: 1

Abstract

Heart rate variability (HRV) analysis is a useful method to assess abnormal functioning in the autonomic nervous system and to predict cardiac events in patients with heart failure (HF). HRV measurements with heart rate monitors have been validated with an electrocardiograph in healthy subjects but not in patients with HF. We explored the reproducibility of HRV in two consecutive six-minute walk tests (6MW), 60-minute apart, using a heart rate monitor (PolarS810i) and a portable electrocardiograph (called Holter) in 50 HF patients (mean age 59 years, NYHA II, left ventricular ejection fraction similar to 35%). The reproducibility for each device was analysed using a paired t-test or the Wilcoxon signed-rank test. Additionally, we assessed the agreement between the two devices based on the HRV indices at rest, during the 6MW and during recovery using concordance correlation coefficients (CCC), 95% confidence intervals and Bland-Altman plots. The test-retest for the HRV analyses was reproducible using Holter and PolarS810i at rest but not during recovery. In the second 6MW, patients showed significant increases in rMSSD and walking distance. The PolarS810i measurements had remarkably high concordance correlation {[}0.86<CCC<0.99] based on Holter at rest, during 6MW and recovery. At higher rates, a small effect in increasing differences between Holter and Polar in R-R intervals was observed. In conclusion, our study showed good reproducibility of HRV at rest in two consecutive 6MW using Holter and PolarS810i. Additionally, PolarS810i produced good agreements in short-term HRV indices based on Holter simultaneous recordings at rest, during the 6MW and recovery in HF patients. (AU)

• FAPESP's process: 13/13598-1 - Physiotherapy: functionality and biomolecular and cellular study in the treatment of patients with cardiorespiratory dysfunctions
• Grantee: Naomi Kondo Nakagawa
• Support Opportunities: Regular Research Grants